| 摘要 |
The present invention relates to materials and procedures for evaluating the prognosis of patients suffering from acute coronary syndromes. In particular , the level of BNP, or a marker related to BNP, in a patient sample, alone or in combination with one or more other prognostic markers, provides prognostic information useful for predicting near-term morbidity and/or mortality acros s the entire spectrum of acute coronary syndromes, including unstable angina, non-ST-elevation non-Q wave myocardial infarction, ST-elevation non-Q wave M I, and transmural (Q-wave) MI.
|
